|
Robin Blaney is an associate in the London Life Sciences practice. He joined Covington as a trainee solicitor in September 2004.
Mr. Blaney has broad experience in the life sciences sector including involvement in corporate, commercial, litigation, data privacy, and regulatory matters. He has gained particular experience in licensing, collaborative, and commercial transactions for life sciences clients. His regulatory practice includes pharmaceutical, medical device, food, and consumer product regulation.
Representative Matters
- Advising Novartis Vaccines and Diagnostics on a wide variety of transactions and commercial matters.
- Regulatory advice to a number of the major national and multinational pharmaceutical companies and biotechnology, diagnostic, medical device, and consumer product manufacturers in the United Kingdom and mainland Europe
- Assistance to clients with applications for the centralized approval of medicinal products and for EC orphan drug designation, and with regulatory issues in the national approval process for medicines, including the EC decentralized and mutual recognition procedures.
- Participation in formal and informal good manufacturing practices (GMP), good clinical practices (GCP), clinical trials, advertising, borderline, drug safety, and pharmacovigilance regulatory and enforcement proceedings before the European Medicines Agency (EMEA), national authorities, courts, and self-regulatory bodies.
- Participation in compliance-related investigations and initiatives in respect of alleged breaches of medicines advertising, anti-bribery, clinical trials, and pharmacovigilance rules.
- Product defense resulting from regulatory challenges to product claims and borderline product classifications.
Publications and Speeches
- "Key Issues in Contract Manufacturing Agreements," Falconbury Seminar on Pharma Contracts (11/15/2011)
- "Examining the EU Falsified Medicines directive," 1st Annual Pharmaceutical Packaging and Artwork Conference (10/19/2011)
- "Legal Perspective on medical devices labelling: Understanding and overcoming challenges," 5th Annual Labelling and Packaging Compliance for Medical Devices & IVDs (10/19/2011)
|
|